Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Kaneka Ubiquinol is the active, reduced form of CoQ10 that supports cellular energy production through mitochondrial ATP synthesis. It provides superior bioavailability compared to standard ubiquinone CoQ10, making it more effective for cardiovascular and energy support.
Reported Benefits (Provisional)
Origin & History
Kaneka Ubiquinol is a reduced form of CoQ10, produced through a yeast fermentation process that enhances its bioavailability and absorption.
Research Narrative (Provisional)
Numerous studies, including RCTs, have shown Kaneka Ubiquinol's effectiveness in improving cardiovascular health and reducing oxidative stress.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Kaneka Ubiquinol is the reduced, active antioxidant form of Coenzyme Q10 (CoQ10), produced via yeast fermentation by Kaneka Corporation. It is not a macronutrient source and contains negligible calories, protein, fat, or carbohydrates at typical supplemental doses. The primary bioactive compound is ubiquinol (reduced CoQ10, QH2) at typical supplemental concentrations of 50–200 mg per dose. Ubiquinol carries two extra electrons compared to ubiquinone (oxidized CoQ10), making it immediately bioavailable as an antioxidant without requiring enzymatic conversion. Bioavailability is significantly superior to ubiquinone: studies indicate ubiquinol achieves approximately 2–4x higher plasma CoQ10 levels compared to equivalent ubiquinone doses. Peak plasma absorption is enhanced when taken with dietary fat (lipophilic compound). Kaneka Ubiquinol is typically delivered in softgel form with carrier oils (e.g., medium-chain triglycerides or sunflower oil) to further enhance absorption. No significant vitamin, mineral, or fiber content is present. The compound functions as a fat-soluble antioxidant and electron carrier in the mitochondrial electron transport chain (Complex I and III), directly participating in ATP synthesis. Typical effective plasma levels target 2.5–3.5 mcg/mL following supplementation.
Reported Mechanism (Provisional)
Ubiquinol functions as an electron carrier in the mitochondrial electron transport chain, specifically between Complex I/II and Complex III, facilitating ATP production. It also acts as a potent lipophilic antioxidant, protecting cell membranes from lipid peroxidation and regenerating other antioxidants like vitamin E and vitamin C.
Clinical Narrative (Provisional)
Clinical trials with ubiquinol show improvements in ejection fraction and reduced heart failure symptoms in doses of 100-300mg daily. Studies demonstrate 3-8x better absorption than ubiquinone CoQ10, with measurable increases in plasma CoQ10 levels within 2-4 weeks. Research includes randomized controlled trials with 50-420 participants showing benefits for statin-induced myopathy and exercise performance. Evidence is strongest for cardiovascular applications, with moderate evidence for fatigue reduction.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.